Brian Mills joined Pivotal Life Science's investment team in 2022. He previously worked as a research analyst at Jefferies and as a postdoctoral scholar at Stanford University.
What Brian can write
Pivotal bioVenture Partners writes $3M to $30M checks, larger than 93% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Pivotal bioVenture Partners.Career
- Stanford University · postdoctoral scholar
- Jefferies · research analyst
- Pivotal Life Science · Vice President2022
- Pivotal bioVenture Partners · Vice PresidentNow
Focus
Education
Also at Pivotal bioVenture Partners
Partners like Brian
At firms with a similar stage, sector and check size.
Alert me when Pivotal bioVenture Partners is active
One email when Brian's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Brian Mills?
Brian Mills joined Pivotal Life Science's investment team in 2022. He previously worked as a research analyst at Jefferies and as a postdoctoral scholar at Stanford University.
How much does Brian Mills invest?
Brian Mills invests through Pivotal bioVenture Partners, which writes checks of $3M to $30M at pre-seed, seed, series a, series b.
How do I pitch Brian Mills?
A warm intro from a founder Pivotal bioVenture Partners backed works best. A short LinkedIn note with one line on traction is the next best route.
What did Brian Mills do before Pivotal bioVenture Partners?
postdoctoral scholar at Stanford University; research analyst at Jefferies; Vice President at Pivotal Life Science.
Last updated 2026-10-15. Is this you? Ask for a correction.